Vanda Pharmaceuticals (VNDA) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q4 2025 value amounting to 0.67.
- Vanda Pharmaceuticals' Equity Ratio fell 1846.42% to 0.67 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.67, marking a year-over-year decrease of 1846.42%. This contributed to the annual value of 0.67 for FY2025, which is 1846.42% down from last year.
- Per Vanda Pharmaceuticals' latest filing, its Equity Ratio stood at 0.67 for Q4 2025, which was down 1846.42% from 0.78 recorded in Q3 2025.
- Over the past 5 years, Vanda Pharmaceuticals' Equity Ratio peaked at 0.86 during Q1 2021, and registered a low of 0.67 during Q4 2025.
- Over the past 5 years, Vanda Pharmaceuticals' median Equity Ratio value was 0.83 (recorded in 2024), while the average stood at 0.82.
- As far as peak fluctuations go, Vanda Pharmaceuticals' Equity Ratio skyrocketed by 206.89% in 2023, and later tumbled by 1846.42% in 2025.
- Vanda Pharmaceuticals' Equity Ratio (Quarter) stood at 0.85 in 2021, then decreased by 2.25% to 0.83 in 2022, then increased by 1.1% to 0.84 in 2023, then fell by 2.34% to 0.82 in 2024, then fell by 18.46% to 0.67 in 2025.
- Its Equity Ratio was 0.67 in Q4 2025, compared to 0.78 in Q3 2025 and 0.78 in Q2 2025.